This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated HPX Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-HPX WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~51.7 kDa | |
| Observed band | ≈72 kDa | |
| Gel | 5–20% (catalog A02237-2) | |
| Negative control | Suggested KO / knockdown lysate |
| PTM | Glycosylated + Cleaved | |
| Caveat | Glycosylation-state controls | |
| Gene-set association | MSigDB C7 membership | |
| Isoform | 1 isoform(s) |
The A02237-2 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | human HepG2, human HCCT, human HCCP (catalog A02237-2) |
| Gel % | 5–20% (catalog A02237-2) |
| Load | 30 ug; reducing conditions (catalog A02237-2) |
| Transfer | a nitrocellulose membrane at 150 mA for 50-90 minutes (catalog A02237-2) |
| Membrane | nitrocellulose membrane (catalog A02237-2) |
| Blocking | 5% non-fat milk/TBS for 1.5 hour at RT (catalog A02237-2) |
| Primary antibody | A02237-2 · 0.5 μg/mL (catalog A02237-2) |
| Primary incubation | overnight at 4°C (catalog A02237-2) |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:5000 (catalog A02237-2) |
| Secondary incubation | 1.5 hour at RT (catalog A02237-2) |
| Wash | TBS-0.1%Tween 3 times with 5 minutes each (catalog A02237-2) |
| Detection | ECL (catalog A02237-2) |
HPX is predicted at 51.7 kDa and observed near 72 kDa; the cause of that difference is not established by the supplied evidence.
| Band near 72 kDa | Empirical HPX band in reducing lysate blots; confirm identity with appropriate controls. |
| Band near 51.7 kDa | Near the predicted full-length precursor mass; identity requires confirmation. |
| Band slightly below precursor | May reflect cleavage of the 1–23 signal peptide; the migration change is unmeasured. |
| Little or no lysate band | HPX is secreted, so it may be more abundant outside cells. |
| Broad band around 72 kDa | Glycoform variation is possible, but the listed sites do not establish a smear. |
| Predicted full-length mass | 51.7 kDa is the sequence-based precursor mass; reducing lysate blots show a band near 72 kDa, with the difference unexplained. |
| Signal peptide at residues 1–23 | Cleavage makes mature HPX smaller than its precursor; the migration change is unmeasured. |
| O-linked glycosylation at Thr24 and Thr29 | May affect apparent migration; its contribution to the 72 kDa band is unmeasured. |
| Complex N-linked glycosylation at Asn64, Asn187 and Asn453 | May affect apparent migration; the size effect is unmeasured. |
| N-linked glycosylation at Asn240 and Asn246 | May affect apparent migration; the size effect is unmeasured. |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | Secreted HPX may be scarce in the cell fraction. | Check conditioned medium alongside a positive lysate control. |
| Band higher than expected | The empirical HPX band is near 72 kDa, above the 51.7 kDa predicted precursor mass; the cause is unestablished. | Compare with a validated HPX positive control and test band identity by HPX depletion. |
| Band lower than expected | Signal-peptide cleavage can reduce mass, but a large shift has no established explanation here. | Compare precursor and mature samples and confirm the band with HPX depletion. |
| Broad smear instead of sharp band | Variation among glycosylated HPX molecules is possible but unproven. | Compare untreated and deglycosylated aliquots with an HPX positive control. |
| Multiple bands | Glycosylation or signal-peptide processing may contribute, but distinct bands are not established. | Compare with a positive control and check which bands disappear after HPX depletion. |
| Weak or no signal | Secreted HPX may be low in the tested fraction. | Test conditioned medium and a validated positive control. |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No high/medium HPA tissues identified in the supplied evidence. | ||||
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No lower-expression tissue rows available in the supplied evidence. | ||||
Deeper troubleshooting and optimisation questions for HPX, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
Both listed anti-HPX antibodies have Western blot images. A02237-2 shows an approximately 72 kDa band in human, rat, and mouse samples, matching its stated expected size. M02237 shows an approximately 70 kDa band in human samples, versus a stated expected size of 52 kDa.
Which to pick: Choose A02237-2 for human, mouse, or rat samples based on the reported reactivity and illustrated lanes. M02237 is listed for human samples only; its illustrated human lanes show a band at 70 kDa, so consider the discrepancy from its stated 52 kDa expectation.